-
Innovation Ranking
NewInnovation Ranking – CK Hutchison Holdings Ltd
CK Hutchison Holdings Ltd (CK Hutchison) is a conglomerate that offers a range of services for various industries including retail, infrastructure, energy, finance and investment and telecommunications sectors. Its offerings include port development, ship and cargo services, energy infrastructure services, mobile and broadband-related services, and manufacturing and distribution of healthcare, personal care, medicines, related products to the consumers. CK Hutchison also earns returns from investments in companies such as Hutchison Whampoa (China), Hutchison China MediTech, CK Life Sciences, TOM Group,...
-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – CK-0803 in Amyotrophic Lateral Sclerosis
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - CK-0803 in Amyotrophic Lateral Sclerosis report and make more profitable business decisions. This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. CK-0803 in Amyotrophic Lateral Sclerosis Drug Details: CK-0803 is under...
-
Product Insights
CK Gold Project
The CK Gold Project is a gold project in United States. It is currently at the feasibility stage. Empower your strategies with our CK Gold Project report and make more profitable business decisions. Note: This is an on-demand report that will be delivered upon request. The report will be delivered within 2 to 3 business days of the purchase, excluding weekends and holidays. Certain sections of the report may be removed or altered based on data availability and relevance. Reasons...
-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – CK-586 in Diastolic Heart Failure (HFpEF)
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - CK-586 in Diastolic Heart Failure (HFpEF) report and make more profitable business decisions.This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. CK-586 in Diastolic Heart Failure (HFpEF) Drug Details: CK-4021586 (CK-586)...
-
Company Insights
Innovation and Patenting activity of CK Asset Holdings Ltd Q4 2023
GlobalData, the industry analysis specialist, has released its latest company patent databook "Innovation and Patenting activity of CK Asset Holdings Ltd Q4 2023". The databook highlights patenting activity of the company in terms of growth in filings and grants, regions protected, impact of various themes, sector applicability of technologies protected. It provides contextual analysis of technical peers, their strategy, dominance (Grant share) and their recent activities. This is an on-demand databook that will be delivered upon request. The report will...
-
Company Insights
Innovation and Patenting activity of CK Infrastructure Holdings Ltd Q4 2023
GlobalData, the industry analysis specialist, has released its latest company patent databook "Innovation and Patenting activity of CK Infrastructure Holdings Ltd Q4 2023". The databook highlights patenting activity of the company in terms of growth in filings and grants, regions protected, impact of various themes, sector applicability of technologies protected. It provides contextual analysis of technical peers, their strategy, dominance (Grant share) and their recent activities. This is an on-demand databook that will be delivered upon request. The report will...
-
Company Insights
Innovation and Patenting activity of CK Hutchison Holdings Ltd Q4 2023
GlobalData, the industry analysis specialist, has released its latest company patent databook "Innovation and Patenting activity of CK Hutchison Holdings Ltd Q4 2023". The databook highlights patenting activity of the company in terms of growth in filings and grants, regions protected, impact of various themes, sector applicability of technologies protected. It provides contextual analysis of technical peers, their strategy, dominance (Grant share) and their recent activities. This is an on-demand databook that will be delivered upon request. The report will...
-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – CK-0045 in Obesity
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - CK-0045 in Obesity report and make more profitable business decisions.This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. CK-0045 in Obesity Drug Details: CK-0045 is under development for the treatment of...
-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – CK-0801 in Myelofibrosis
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - CK-0801 in Myelofibrosis report and make more profitable business decisions.This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data.CK-0801 in Myelofibrosis Drug Details:CK-0801 is under development for the treatment of inflammatory disorders...
-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – CK-0801 in Aplastic Anemia
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - CK-0801 in Aplastic Anemia report and make more profitable business decisions.This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data.CK-0801 in Aplastic Anemia Drug Details:CK-0801 is under development for the treatment of...